Literature DB >> 28665284

Multiple sclerosis - etiology and diagnostic potential.

Joanna Kamińska1, Olga M Koper1, Kinga Piechal2, Halina Kemona1.   

Abstract

Multiple sclerosis (MS) is a chronic inflammatory and demyelinating disease of autoimmune originate. The main agents responsible for the MS development include exogenous, environmental, and genetic factors. MS is characterized by multifocal and temporally scattered central nervous system (CNS) damage which lead to the axonal damage. Among clinical courses of MS it can be distinguish relapsing-remitting multiple sclerosis (RRMS), secondary progressive multiple sclerosis (SPSM), primary progressive multiple sclerosis (PPMS), and progressive-relapsing multiple sclerosis (RPMS). Depending on the severity of signs and symptoms MS can be described as benign MS or malignant MS. MS diagnosis is based on McDonald's diagnostic criteria, which link clinical manifestation with characteristic lesions demonstrated by magnetic resonance imaging (MRI), cerebrospinal fluid (CSF) analysis, and visual evoked potentials. Among CSF laboratory tests used to the MS diagnosis are applied: Tibbling & Link IgG index, reinbegrams, and CSF isoelectrofocusing for oligoclonal bands detection. It should be emphasized, that despite huge progress regarding MS as well as the availability of different diagnostics methods this disease is still a diagnostic challenge. It may result from fact that MS has diverse clinical course and there is a lack of single test, which would be of appropriate diagnostic sensitivity and specificity for quick and accurate diagnosis.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28665284     DOI: 10.5604/01.3001.0010.3836

Source DB:  PubMed          Journal:  Postepy Hig Med Dosw (Online)        ISSN: 0032-5449            Impact factor:   0.270


  15 in total

1.  IL-6 Quotient (The Ratio of Cerebrospinal Fluid IL-6 to Serum IL-6) as a Biomarker of an Unruptured Intracranial Aneurysm.

Authors:  Joanna Kamińska; Violetta Dymicka-Piekarska; Robert Chrzanowski; Karol Sawicki; Anna J Milewska; Justyna Zińczuk; Marzena Tylicka; Marek Jadeszko; Zenon Mariak; Ewa M Kratz; Joanna Matowicka-Karna; Johannes Kornhuber; Piotr Lewczuk; Olga M Koper-Lenkiewicz
Journal:  J Inflamm Res       Date:  2021-11-23

Review 2.  Risk Factors from Pregnancy to Adulthood in Multiple Sclerosis Outcome.

Authors:  Enrique González-Madrid; Ma Andreina Rangel-Ramírez; María José Mendoza-León; Oscar Álvarez-Mardones; Pablo A González; Alexis M Kalergis; Ma Cecilia Opazo; Claudia A Riedel
Journal:  Int J Mol Sci       Date:  2022-06-25       Impact factor: 6.208

Review 3.  Prevalence of depression and anxiety in the different clinical forms of multiple sclerosis and associations with disability: A systematic review and meta-analysis.

Authors:  Diulle Spat Peres; Patrícia Rodrigues; Fernanda Tibolla Viero; Julia Maria Frare; Sabrina Qader Kudsi; Graziela Moro Meira; Gabriela Trevisan
Journal:  Brain Behav Immun Health       Date:  2022-07-06

Review 4.  Involvement of the Intestinal Microbiota in the Appearance of Multiple Sclerosis: Aloe vera and Citrus bergamia as Potential Candidates for Intestinal Health.

Authors:  Jessica Maiuolo; Vincenzo Musolino; Micaela Gliozzi; Cristina Carresi; Federica Scarano; Saverio Nucera; Miriam Scicchitano; Francesca Oppedisano; Francesca Bosco; Roberta Macri; Ernesto Palma; Carolina Muscoli; Vincenzo Mollace
Journal:  Nutrients       Date:  2022-06-29       Impact factor: 6.706

5.  Searching for the Relationship between the Concentration of Heavy Metals in the Blood and the Clinical Course of Multiple Sclerosis: A Cross-Sectional Study in Poland.

Authors:  Anna Knyszyńska; Karolina Skonieczna-Żydecka; Dorota Koziarska; Laura Stachowska; Artur Kotwas; Monika Kulaszyńska; Anna Lubkowska; Beata Karakiewicz
Journal:  Int J Environ Res Public Health       Date:  2022-05-27       Impact factor: 4.614

Review 6.  Long Non-coding RNA HOTAIR in Central Nervous System Disorders: New Insights in Pathogenesis, Diagnosis, and Therapeutic Potential.

Authors:  Jialu Wang; Jiuhan Zhao; Pan Hu; Lianbo Gao; Shen Tian; Zhenwei He
Journal:  Front Mol Neurosci       Date:  2022-06-23       Impact factor: 6.261

7.  Seroprevalence of anti-Toxocara antibody among multiple sclerosis patients: a case-control study.

Authors:  Nastaran Khalili; Neda Khalili; Ali Nickhah; Bahman Khalili
Journal:  J Parasit Dis       Date:  2019-10-29

8.  Matrix metalloproteinases (MMPs) family gene polymorphisms and the risk of multiple sclerosis: systematic review and meta-analysis.

Authors:  Mina Mohammadhosayni; Arezou Khosrojerdi; Keivan Lorian; Saeed Aslani; Danyal Imani; Bahman Razi; Farhad Babaie; Shahram Torkamandi
Journal:  BMC Neurol       Date:  2020-05-29       Impact factor: 2.474

Review 9.  Kv1.3 Channel as a Key Therapeutic Target for Neuroinflammatory Diseases: State of the Art and Beyond.

Authors:  Xiaoli Wang; Guoyi Li; Jingkang Guo; Zhiping Zhang; Shuzhang Zhang; Yudan Zhu; Jiwei Cheng; Lu Yu; Yonghua Ji; Jie Tao
Journal:  Front Neurosci       Date:  2020-01-14       Impact factor: 4.677

10.  IL-37 exerts therapeutic effects in experimental autoimmune encephalomyelitis through the receptor complex IL-1R5/IL-1R8.

Authors:  Alba Sánchez-Fernández; Stephanie Zandee; Jesús Amo-Aparicio; Marc Charabati; Alexandre Prat; Cecilia Garlanda; Elan Z Eisenmesser; Charles A Dinarello; Rubèn López-Vales
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.